Cartesian Therapeutics
RNAC
#6811
Rank
A$0.77 B
Marketcap
$30.39
Share price
-1.30%
Change (1 day)
-3.50%
Change (1 year)

Earnings for Cartesian Therapeutics (RNAC)

Earnings in 2024 (TTM): -A$0.4 Billion

According to Cartesian Therapeutics's latest financial reports the company's current earnings are A$47.93 Million. In 2023 the company made an earning of -A$0.38 Billion a decrease over its 2022 earnings that were of A$60.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cartesian Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$0.4 Billion3.5%
2023 -A$0.38 Billion-724%
2022 A$60.4 M-649.67%
2021 -A$10.99 Million-89.78%
2020 -A$0.11 Billion25.06%
2019 -A$86.03 Million-15.68%
2018 -A$0.11 Billion-0.43%
2017 -A$0.11 Billion83.41%
2016 -A$55.87 Million44.3%
2015 -A$38.72 Million